Clinical Trial

To Evaluate Efficacy of Monotherapy of Oxcarbazepine Versus Combination of Gabapentin With Oxcarbazepine in the Management of Trigeminal Neuralgia

Completed Phase 2/3
View on ClinicalTrials.gov →
Summary
ABSTRACT: Objective: This study evaluates the effectiveness of oxcarbazepine monotherapy with the combination of gabapentin and oxcarbazepine in managing trigeminal neuralgia(TN). Methods: A prospective observational study was conducted at Rehman College of Dentistry for the duration of one year, i.e., from 1st May 2023 till May 2024. A total of 44 patients, fulfilling inclusion criteria, were included.Half were given monotherapy with oxcarbazepine (300 mg twice daily) and half were given combination therapy with gabapentin (100 mg daily) plus oxcarbazepine. Pain was evaluated utilizing the Visual Analogue Scale (VAS) at baseline, 2 weeks, and 2 months. SPSS software version 26 was used for statistical analysis. KEYWORDS: Combination Therapy, Gabapentin, Monotherapy, Oxcarbazepine, Trigeminal Neuralgia, Visual Analogue Scale.
Trial Details
NCT Number NCT07625410
Lead Sponsor Rehman Medical Institute - RMI
Conditions Effectiveness of Drugs Was Compared for Treating Trigeminal Neuralgia, Pain, Pain Management
Enrollment 44 participants
Start Date 2023-05-01
Primary Completion 2024-05-01 (estimated)
Study Completion 2024-05-01 (estimated)
Updated on ClinicalTrials.gov 2026-06-04